Last update 12 Jun 2025

BNT-114

Overview

Basic Info

Drug Type
Personalized antigen vaccine, Therapeutic vaccine
Synonyms
IVAC W bre1 uID, IVAC_W_bre1_uID, BNT-114
Target-
Action
stimulants
Mechanism
Immunostimulants
Therapeutic Areas
NeoplasmsSkin and Musculoskeletal Diseases
Active Indication-
Inactive Indication
Triple Negative Breast Cancer
Originator Organization
BioNTech SEBioNTech SE
Active Organization-
Inactive Organization
BioNTech SEBioNTech SE
License Organization-
Drug Highest PhasePendingPhase 1
First Approval Date-
Regulation-

Related

1
Clinical Trials associated with BNT-114
NCT02316457
/ CompletedPhase 1
First-in-human Clinical Study With RNA-Immunotherapy Combination of IVAC_W_bre1_uID and IVAC_M_uID for Individualized Tumor Therapy in Triple Negative Breast Cancer Patients
100 Clinical Results associated with BNT-114
Login to view more data
100 Translational Medicine associated with BNT-114
Login to view more data
100 Patents (Medical) associated with BNT-114
Login to view more data
100 Deals associated with BNT-114
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Triple Negative Breast CancerPhase 1
Germany
BioNTech SEBioNTech SE
01 Oct 2016
Triple Negative Breast CancerPhase 1
Sweden
BioNTech SEBioNTech SE
01 Oct 2016
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free